Hillsdale Investment Management Inc. Lowers Holdings in Bristol-Myers Squibb (NYSE:BMY)
Hillsdale Investment Management Inc. lessened its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 37.3% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,394 shares of the biopharmaceutical company’s stock after selling 830 shares during the quarter. Hillsdale Investment Management Inc.’s holdings in Bristol-Myers Squibb […]
More Stories
Pacer Emerging Markets Cash Cows 100 ETF (NASDAQ:ECOW) Short Interest Up 800.0% in December
Pacer Emerging Markets Cash Cows 100 ETF (NASDAQ:ECOW – Get Free Report) saw a large increase in short interest in...
Micron Technology (NASDAQ:MU) Stock Price Down 0.1% on Insider Selling
Micron Technology, Inc. (NASDAQ:MU – Get Free Report)’s share price fell 0.1% during mid-day trading on Thursday after an insider...
Centessa Pharmaceuticals plc (NASDAQ:CNTA) Insider Gregory M. Weinhoff Sells 10,000 Shares
Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) insider Gregory M. Weinhoff sold 10,000 shares of the firm’s stock in...
Analysts Set Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Price Target at $166.00
Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) have earned an average recommendation of “Moderate Buy” from the...
Applied Materials, Inc. (NASDAQ:AMAT) Given Average Recommendation of “Moderate Buy” by Analysts
Applied Materials, Inc. (NASDAQ:AMAT – Get Free Report) has been given an average rating of “Moderate Buy” by the twenty-two...
Quest Resource Holding Co. (NASDAQ:QRHC) Director Glenn Culpepper Buys 2,000 Shares
Quest Resource Holding Co. (NASDAQ:QRHC – Get Free Report) Director Glenn Culpepper bought 2,000 shares of the company’s stock in...